HAX1 and breast carcinoma: In MDA-MB-231 breast cancer cell lines resistant to cisplatin or doxorubicin, inhibiting hematopoietic cell-specific protein 1-associated protein X-1 (HAX-1) can induce the release of cyt c from mitochondria, which helps restore the sensitivity of breast cancer cells to chemotherapy drugs [34].